VERACITY is an accurate, safe, affordable and fast non-invasive prenatal test for the detection of fetal chromosomal aneuploidies and microdeletions in single and twin pregnancies. It can be performed starting from the 10th week of pregnancy. The test is safe for the mother and the fetus as it only needs a blood sample drawn from the mother’s arm. The sensitivity, specificity and robustness of VERACITY has been demonstrated in three clinical validation studies using hundreds of samples.
What can VERACITY detect?
Trisomy 21 Down syndrome
Trisomy 18 Edwards syndrome
Trisomy 13 Patau syndrome
SEX CHROMOSOME ANEUPLOIDIES (only in single pregnancies)
45, X Turner syndrome
47, XXX Triple X syndrome
47, XXY Klinefelter syndrome
47, XYY Jacob syndrome
22q11.2 DiGeorge syndrome
1p36 1p36 deletion syndrome
17p11.2 Smith-Magenis syndrome
4p16.3 Wolf-Hirschhorn syndrome
What are the advantages of VERACITY?
Non-invasive test using a simple blood draw from the arm with no risk for the mother and the fetus
Higher than 99% sensitivity and specificity in detecting fetal trisomies
Can be done as early as 10 weeks, fast results within a few days
Validated in three multi-center studies using hundreds of samples. Used by health professionals around the world.
How can I be tested?
VERACITY can be done starting from the 10th week of pregnancy.
Talk to your doctor about VERACITY
Your doctor or lab will collect a sample and send it for analysis.
cfDNA is isolated and analysed using VERACITY.
VERACITY results are available through your doctor in a few days.
Your doctor will contact you to discuss VERACITY results.
VERACITY is a new generation non-invasive prenatal test which accurately detects Down syndrome, Edwards syndrome and Patau syndrome, three of the most common fetal genetic disorders as well as other syndromes caused by X and Y chromosome aneuploidies. VERACITY also provides the option to know the gender of the baby.
Non-invasive prenatal testing is important because it provides a safe and accurate way to test the baby before birth for genetic disorders, the most common of which is Down syndrome. Before the introduction of this revolutionary test, the options to test for Down syndrome were either screening methods like ultrasound combined with other lab testing which have low accuracy (approximately 80-95%) or high accuracy prenatal diagnosis that uses invasive methods [e.g. amniocentesis or chorionic villi sampling (CVS)] which have 0.5% risk for miscarriage. VERACITY is a new generation non-invasive prenatal test that has significantly greater accuracy (>99%) and no risk for miscarriage.
Down syndrome, Edwards syndrome and Patau syndrome are genetic disorders caused by chromosomal trisomies. Down syndrome is caused by an extra copy of chromosome 21 whereas Edwards syndrome and Patau syndrome are caused by an extra copy of chromosome 18 and chromosome 13, respectively. Down syndrome is characterized by intellectual impairment and congenital abnormalities. Down syndrome occurs approximately in 1 in 700 pregnancies but is more frequent in pregnancies in women over 35. Edwards syndrome and Patau syndrome are less common occurring in 1 in 3000 and 1 in 10000 pregnancies, respectively. Edwards and Patau syndromes are characterized by severe congenital abnormalities and rarely survive past the first year of life.
Ask your doctor about using VERACITY to detect these fetal trisomies.
Sex chromosome aneuploidies are genetic diseases caused by the presence or absence of a sex chromosome. The 23rd pair of chromosomes determine the sex of an individual. Women have two X chromosomes and men have one X and one Y chromosome. There are four major sex chromosome aneuploidies:
Turner syndrome is characterized by the presence of a single X chromosome.
Triple X syndrome is characterized by the presence of three X chromosomes.
Klinefelter syndrome is characterized by the presence of two X chromosomes and one Y chromosome.
Jacob syndrome is characterized by the presence of one X chromosome and two Y chromosomes.
Ask your doctor about using VERACITY to detect these fetal chromosomal aneuploidies.
Microdeletions are genetic conditions caused by the loss of a part of a chromosome. Microdeletions are characterized by congenital abnormalities and intellectual impairment. The severity of the symptoms varies depending on the size and location of the microdeletion. The most common microdeletion syndrome is DiGeorge syndrome which occurs approximately once in 1000 pregnancies. The prevalence of DiGeorge syndrome increases to 1 in 100 in pregnancies with major structural anomalies such as congenital heart disease.
VERACITY is a new generation non-invasive prenatal with unparalleled accuracy. VERACITY can be done for all singleton pregnancies after the 10th week of pregnancy and pregnancies conceived through in-vitro fertilization (IVF).
The high accuracy of VERACITY has been demonstrated in several clinical validation studies using hundreds of samples. VERACITY is fast, providing results to your doctor in a few days upon sample receipt to our laboratory. VERACITY is a safe test for both the mother and the fetus because it is performed using a simple blood draw.
VERACITY requires a blood draw which is perfomed by your doctor or healthcare provider. The blood sample is sent to our laboratory and the results are provided to your doctor in few days. Your doctor or healthcare provider will discuss your VERACITY results and provide counseling.
VERACITY is a new generation targeted non-invasive prenatal test. Its unique state-of-the-art design that confers unparalled accuracy also makes it a highly affordable test for the detection of fetal chromosomal aneuploidies. Please contact your healthcare provider regarding the cost of VERACITY and payment options in your country.